Argenica Therapeutics Limited (AGN.AX)
AUD 0.62
(-3.13%)
AUD 0.62
(-3.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -5.06 Million | -3.3 Million | -3.36 Million | -1.04 Million | -58.81 Thousand |
| Net Income | -5.47 Million | -4.81 Million | -4.09 Million | -1.02 Million | -383.4 Thousand |
| Depreciation & Amortization | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 141.19 Thousand | 460.35 Thousand | 425.33 Thousand | 268.21 Thousand | - |
| Change in working capital | 277.73 Thousand | 1.05 Million | 303.74 Thousand | -285.12 Thousand | 324.58 Thousand |
| Other non-cash items | -73.82 Thousand | 72.57 Thousand | 139.3 Thousand | 560.53 Thousand | -324.58 Thousand |
| Investing Cash Flow | 50 Thousand | -50 Thousand | - | - | - |
| Investments in PPE | 5.06 Million | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | -50 Thousand | - | - | - |
| Sales/Maturities of investments | 50 Thousand | - | - | - | - |
| Other Investing Activities | 50 Thousand | -50 Thousand | - | - | - |
| Financing Cash Flow | 11.63 Million | 3.72 Million | 5.13 Million | 7.84 Million | 400.8 Thousand |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 11.63 Million | 3.72 Million | 5.13 Million | 7.84 Million | 400.8 Thousand |
| Other Financing Activities | 11.63 Million | 3.72 Million | 5.13 Million | 7.84 Million | 687.08 Thousand |
| Accounts receivables | -230.83 Thousand | -72.76 Thousand | -671.00 | -92.59 Thousand | -34.67 Thousand |
| Accounts payables | 445.85 Thousand | 460.54 Thousand | 286.7 Thousand | -199.72 Thousand | 359.26 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 62.71 Thousand | 666.6 Thousand | 17.7 Thousand | 7191.00 | - |
| Cash at beginning of period | 9.28 Million | 8.91 Million | 7.14 Million | 341.98 Thousand | 1.00 |
| Cash at end of period | 15.91 Million | 9.28 Million | 8.91 Million | 7.14 Million | 341.98 Thousand |
| Capital Expenditure | 5.06 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 6.62 Million | 374.69 Thousand | 1.77 Million | 6.8 Million | 341.98 Thousand |
| Free Cash Flow | - | -3.3 Million | -3.36 Million | -1.04 Million | -58.81 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.47 Million | -2.03 Million | -2.03 Million | -704.77 Thousand | -704.77 Thousand | -3.26 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 20.53 Thousand | 20.53 Thousand | 50.06 Thousand | 50.06 Thousand | 133.25 Thousand |
| Change in working capital | 277.73 Thousand | -106.69 Thousand | -106.69 Thousand | - | - | -32.61 Thousand |
| Other non-cash items | -73.82 Thousand | 159.44 Thousand | 159.44 Thousand | 86.11 Thousand | 86.11 Thousand | 744 Thousand |
| Investing Cash Flow | 50 Thousand | - | - | 25 Thousand | 25 Thousand | -50 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -50 Thousand |
| Sales/Maturities of investments | 50 Thousand | - | - | 50 Thousand | - | - |
| Other Investing Activities | 50 Thousand | - | - | 25 Thousand | 25 Thousand | -25 Thousand |
| Financing Cash Flow | 11.63 Million | 5.7 Million | 5.7 Million | 113.02 Thousand | 113.02 Thousand | 3.73 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.63 Million | - | - | 226.04 Thousand | - | 3.73 Million |
| Other Financing Activities | - | 5.7 Million | 5.7 Million | 113.02 Thousand | 113.02 Thousand | 1.86 Million |
| Accounts receivables | -230.83 Thousand | -115.41 Thousand | -115.41 Thousand | - | - | -36.38 Thousand |
| Accounts payables | 445.85 Thousand | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 62.71 Thousand | 8720.00 | 8720.00 | - | - | 3766.00 |
| Cash at beginning of period | 9.28 Million | - | - | 9.28 Million | - | 8.12 Million |
| Cash at end of period | 15.91 Million | 3.74 Million | 3.74 Million | 8.42 Million | -430.57 Thousand | 9.28 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | 1.00 |
| Net cash flow / Change in cash | 6.62 Million | 3.74 Million | 3.74 Million | -861.15 Thousand | -430.57 Thousand | 1.16 Million |
| Free Cash Flow | -5.06 Million | -1.96 Million | -1.96 Million | -568.6 Thousand | -568.6 Thousand | -2.51 Million |
PCJEWELLER
131970
EMWPF
KOS
123690
OTCFF